PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $45,388,000 | -16.1% | 1,672,979 | +7.3% | 2.65% | -21.2% |
| Q1 2019 | $54,092,000 | +75.2% | 1,558,829 | -1.5% | 3.37% | +42.3% |
| Q4 2018 | $30,883,000 | -1.3% | 1,582,129 | +34.7% | 2.37% | +37.3% |
| Q3 2018 | $31,279,000 | +18.3% | 1,174,555 | +67.8% | 1.73% | +15.0% |
| Q2 2018 | $26,432,000 | +114.7% | 699,820 | +85.7% | 1.50% | +136.8% |
| Q1 2018 | $12,310,000 | -43.1% | 376,913 | -15.2% | 0.63% | -36.2% |
| Q4 2017 | $21,638,000 | -0.4% | 444,513 | +10.5% | 0.99% | +3.8% |
| Q3 2017 | $21,727,000 | +1834.7% | 402,123 | +1910.6% | 0.96% | +1895.8% |
| Q2 2017 | $1,123,000 | -44.8% | 20,000 | -61.5% | 0.05% | -53.4% |
| Q1 2017 | $2,034,000 | +59.3% | 51,900 | -8.8% | 0.10% | +71.7% |
| Q4 2016 | $1,277,000 | +39.9% | 56,900 | +41.5% | 0.06% | +114.3% |
| Q3 2016 | $913,000 | -87.6% | 40,200 | -88.8% | 0.03% | -91.4% |
| Q1 2016 | $7,335,000 | -51.3% | 359,600 | +22.8% | 0.32% | -32.8% |
| Q4 2015 | $15,069,000 | +4.9% | 292,890 | -13.1% | 0.48% | +14.8% |
| Q3 2015 | $14,363,000 | -30.2% | 337,000 | -25.4% | 0.42% | +0.2% |
| Q2 2015 | $20,579,000 | +469.6% | 451,791 | +374.6% | 0.42% | +466.2% |
| Q1 2015 | $3,613,000 | +28.1% | 95,192 | -4.4% | 0.07% | +54.2% |
| Q4 2014 | $2,820,000 | +1142.3% | 99,600 | +1027.5% | 0.05% | +300.0% |
| Q4 2013 | $227,000 | – | 8,834 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|